spacer
spacer

PDBsum entry 1k5o

Go to PDB code: 
protein links
Protein binding PDB id
1k5o

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
86 a.a. *
* Residue conservation analysis
PDB id:
1k5o
Name: Protein binding
Title: Cpi-17(35-120) deletion mutant
Structure: Cpi-17. Chain: a. Fragment: residues 1-86. Synonym: 17-kda pkc-potentiated inhibitory protein of pp1. Engineered: yes
Source: Sus scrofa. Pig. Organism_taxid: 9823. Gene: porcine aorta. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
NMR struc: 1 models
Authors: S.Ohki,M.Eto,E.Kariya,T.Hayano,Y.Hayashi,M.Yazawa,D.Brautigan, M.Kainosho
Key ref:
S.Ohki et al. (2001). Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation. J Mol Biol, 314, 839-849. PubMed id: 11734001 DOI: 10.1006/jmbi.2001.5200
Date:
11-Oct-01     Release date:   11-Oct-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O18734  (PP14A_PIG) -  Protein phosphatase 1 regulatory subunit 14A from Sus scrofa
Seq:
Struc:
147 a.a.
86 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1006/jmbi.2001.5200 J Mol Biol 314:839-849 (2001)
PubMed id: 11734001  
 
 
Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation.
S.Ohki, M.Eto, E.Kariya, T.Hayano, Y.Hayashi, M.Yazawa, D.Brautigan, M.Kainosho.
 
  ABSTRACT  
 
Contractility of vascular smooth muscle depends on phosphorylation of myosin light chains, and is modulated by hormonal control of myosin phosphatase activity. Signaling pathways activate kinases such as PKC or Rho-dependent kinases that phosphorylate the myosin phosphatase inhibitor protein called CPI-17. Phosphorylation of CPI-17 at Thr38 enhances its inhibitory potency 1000-fold, creating a molecular on/off switch for regulating contraction. We report the solution NMR structure of the CPI-17 inhibitory domain (residues 35-120), which retains the signature biological properties of the full-length protein. The final ensemble of 20 sets of NMR coordinates overlaid onto their mean structure with r.m.s.d. values of 0.84(+/-0.22) A for the backbone atoms. The protein forms a novel four-helix, V-shaped bundle comprised of a central anti-parallel helix pair (B/C helices) flanked by two large spiral loops formed by the N and C termini that are held together by another anti-parallel helix pair (A/D helices) stabilized by intercalated aromatic and aliphatic side-chains. Chemical shift perturbations indicated that phosphorylation of Thr38 induces a conformational change involving displacement of helix A, without significant movement of the other three helices. This conformational change seems to flex one arm of the molecule, thereby exposing new surfaces of the helix A and the nearby phosphorylation loop to form specific interactions with the catalytic site of the phosphatase. This phosphorylation-dependent conformational change offers new structural insights toward understanding the specificity of CPI-17 for myosin phosphatase and its function as a molecular switch.
 
  Selected figure(s)  
 
Figure 3.
Figure 3. The solution NMR structure of CPI-17-[35-120]. (a) Stereo view of the backbone (N, C^a, and C') of 20 superimposed structures. The phosphorylation site T38 is colored orange within the N-terminal region colored yellow. Helices are colored royal-blue. (b) Ribbon representation of an energy-minimized average structure of CPI-17-[35-120]. Helix regions are royal-blue and yellow. The side-chain of Thr38 is depicted by a ball-and-stick model. The first and last residues of each helix are labeled with the residue number and the helices are labeled with upper-case letters. The N-term. and C-term. labels show the positions of the amino and carboxyl ends of the protein, respectively.
Figure 6.
Figure 6. Front and back views of the molecular surface of CPI-17-[35-120] colored according to electrostatic potential. Negative and positive charged areas are colored in red and blue, respectively. Small ribbon models viewed from the identical perspective are drawn at the side of both molecules for orientation. Several amino acid residues are labeled.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2001, 314, 839-849) copyright 2001.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
18954090 B.Dancheck, A.C.Nairn, and W.Peti (2008).
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
  Biochemistry, 47, 12346-12356.  
18073109 M.Eto, T.Kitazawa, F.Matsuzawa, S.Aikawa, J.A.Kirkbride, N.Isozumi, Y.Nishimura, D.L.Brautigan, and S.Y.Ohki (2007).
Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.
  Structure, 15, 1591-1602.
PDB code: 2rlt
15136561 D.J.Hartshorne, M.Ito, and F.Erdödi (2004).
Role of protein phosphatase type 1 in contractile functions: myosin phosphatase.
  J Biol Chem, 279, 37211-37214.  
15184667 M.Eto, T.Kitazawa, and D.L.Brautigan (2004).
Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits.
  Proc Natl Acad Sci U S A, 101, 8888-8893.  
12495628 M.Eto, R.Bock, D.L.Brautigan, and D.J.Linden (2002).
Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor.
  Neuron, 36, 1145-1158.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer